• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    CTBCP

    Dr. David Glasser

    (1933-1989)

    The Dr. David Glasser Memorial Tuberculosis Control and Prevention Award was established in 1996 in honor of Dr. David Glasser's vision of treating tuberculosis with directly observed therapy in Baltimore City. This method was instrumental in reducing the incidence of tuberculosis disease in the City and Maryland. The award is presented an individual for significant contributions to the prevention and control of tuberculosis in Maryland.

    David M. Glasser, MD, MPH, was a clinical pioneer dedicated to improving public health. His main contributions were his work in control of tuberculosis, HIV infection and sexually transmitted diseases.

    As a young medical graduate, he served in Vietnam with the U.S. Army Medical Corps and the Vietnamese government.

    While in Vietnam, he used money smuggled to him in hollowed out books to transform a deteriorating TB hospital to an effective and efficient TB treatment hospital.

    In 1973, he began serving with the Baltimore City Health Department as the Director of the Bureau of Disease Control. At that time, the city had the highest per capita rate of tuberculosis in the nation. He managed this challenge on many fronts. He successfully passed City Council ordinances which overhauled the system for reporting of TB cases, including a requirement that pharmacies report to the health department any patient placed on TB treatment

    This improved identification of TB cases,and provided reliable information on the appropriateness of TB treatment by the private sector. In 1981, he instituted directly observed therapy for most City TB cases, which ensured complete and appropriate treatment.
    ​​​

    At that time only one other city in the U.S. was using DOT, which has now become the world-wide standard of care for TB treatment. He centralized TB treatment in Baltimore City into one clinic and began a program to provide 'TB Clinical Nurse Specialists' who were able to provide a high level of TB care.

    He introduced incentives to promote compliance with TB treatment and collaborated with the City Detention Center and HIV care clinics to establish TB screening and prevention in special populations. He partnered with Johns Hopkins University on public health clinical research. While other U.S. cities had stable or increasing rates of TB in the 1980's and 90's, Baltimore's rate steadily declined (from 35.6 / 100,000 in 1981 to 9.2 in 2001).1

    In other areas of public health, Dr. Glasser was an early proponent of needle-exchange programs and programs for AIDS prevention and education. Patient care was his first priority when he proposed innovative work standards and developed operating procedures for TB care. His ingenuity and dedication significantly influenced the practice of TB control.

    1Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274:945-951.